Create Account | Sign In: Author or Forum

 
 
News  |  Journals  |  Conferences  |  Blogs  |  Articles  |  Forums  |  Twitter    
 

 Headlines:

 

Category: Infections | Reproductive Medicine | Rheumatology | News

Back to Health News

Chlamydia Infection May Play Role in Type of Arthritis

Last Updated: May 06, 2009.

 

Study ties bacterial exposure to tender joints in group of inflammatory diseases

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Study ties bacterial exposure to tender joints in group of inflammatory diseases.

WEDNESDAY, May 6 (HealthDay News) -- Chlamydia infection may play a role in a type of arthritis called undifferentiated spondyloarthropathy (uSpA), a new study finds.

This form of arthritis is a type of spondyloarthritis (SpA), a group of diseases that share clinical features such as inflammatory back pain and inflammation at sites where tendons attach to bones. Other SpAs include ankylosing spondylitis, psoriatic arthritis, inflammatory bowel disease-related arthritis and reactive arthritis (ReA), according to background information in the release.

Chlamydia trachomatis or Chlamydia pneumoniae frequently cause ReA. The new study, published in the May issue of Arthritis & Rheumatism, looked at whether there was a link between these two infections and uSpA.

The University of South Florida researchers compared blood and synovial tissue samples from 26 patients with chronic uSpA or chlamydia-induced ReA with synovial tissue from a control group of 167 osteoarthritis patients. The 26 patients also underwent evaluation of swollen and tender joints and other symptoms of SpA and were asked about known chlamydia infection.

The researchers found that the rate of chlamydia infection in the patients with uSpA was 62 percent, compared with 12 percent in the control group.

More information

The Spondylitis Association of America has more about uSpA.

SOURCE: Arthritis & Rheumatism, news release, April 30, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.


Previous: Cycloset Approved for Type 2 Diabetes Next: Science Zeroes In on New Alzheimer's Drug Target

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

  • Ask a Doctor Teams: Respond to patient questions and discuss challenging presentations with other members.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.